3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Conditions
Ovarian Neoplasms
29
Uterine Cervical Neoplasms
23
Endometrial Neoplasms
14
Breast Neoplasms
10
Neoplasms
8
Uterine Cervical Dysplasia
5
Carcinoma, Ovarian Epithelial
5
Peritoneal Neoplasms
4
Papillomavirus Infections
4
Lung Neoplasms
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Disease
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Primary Ovarian Insufficiency
2
Ovarian Diseases
2
Melanoma
2
Leukemia
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Hyperplasia
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Interventions
Cyclophosphamide
8
pembrolizumab
7
fludarabine
6
aldesleukin
4
Papillomavirus Vaccines
4
Vaccines
3
Radiotherapy
3
Light Coagulation
3
Biopsy
3
spartalizumab
2
fludarabine phosphate
2
entinostat
2
Watchful Waiting
2
Vorinostat
2
VGX-3100
2
Trastuzumab
2
Tomography, X-Ray Computed
2
Surveys and Questionnaires
2
Paclitaxel
2
Observation
2
Nivolumab
2
Interleukin-2
2
Interleukin-12 Subunit p35
2
Early Intervention, Educational
2
Drug Therapy
2
Carboplatin
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
tislelizumab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT03958240
2025-09-15
DECIDE
Institut Claudius Regaud
Phase NA
Recruiting
1,100 enrolled